These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 13129628)

  • 21. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
    Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
    Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.
    McCarthy K; Pearson K; Fulton R; Hewitt J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008368. PubMed ID: 23235660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
    Ma S; Wang J; Han Y; Guo F; Chen C; Chen X; Zou W
    Gynecol Oncol; 2019 Jul; 154(1):246-252. PubMed ID: 31005286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
    Stock RG; Dottino P; Jennings TS; Terk M; DeWyngaert JK; Beddoe AM; Cohen C
    Gynecol Oncol; 1997 Dec; 67(3):309-15. PubMed ID: 9441780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer.
    Abu-Rustum NR; Lee S; Correa A; Massad LS
    Gynecol Oncol; 2001 Apr; 81(1):88-91. PubMed ID: 11277656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?
    Tierney JF; Stewart LA; Parmar MK
    Eur J Cancer; 1999 Mar; 35(3):406-9. PubMed ID: 10448290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined-modality therapy of locally advanced cervical cancer.
    Rose PG
    J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group study.
    Kunos C; Tian C; Waggoner S; Rose PG; Lanciano R
    Int J Gynecol Cancer; 2009 Oct; 19(7):1258-63. PubMed ID: 19823064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
    Eifel PJ
    Nat Clin Pract Oncol; 2006 May; 3(5):248-55. PubMed ID: 16683003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.
    Roberts KB; Urdaneta N; Vera R; Vera A; Gutierrez E; Aguilar Y; Ott S; Medina I; Sempere P; Rockwell S; Sartorelli AC; Fischer DB; Fischer JJ
    Int J Cancer; 2000 Aug; 90(4):206-23. PubMed ID: 10993961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoradiotherapy for cervical cancer.
    Rose PG
    Eur J Cancer; 2002 Jan; 38(2):270-8. PubMed ID: 11803143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy.
    Song S; Song C; Kim HJ; Wu HG; Kim JH; Park NH; Song YS; Kim JW; Kang SB; Ha SW
    Gynecol Oncol; 2012 Jan; 124(1):63-7. PubMed ID: 22004904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications.
    Ferrandina G; Ercoli A; Fagotti A; Fanfani F; Gallotta V; Margariti AP; Salerno MG; Chiantera V; Legge F; Macchia G; Morganti AG; Valentini V; Scambia G
    Ann Surg Oncol; 2014 May; 21(5):1692-9. PubMed ID: 24407316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.
    Gaffney DK; Winter K; Dicker AP; Miller B; Eifel PJ; Ryu J; Avizonis V; Fromm M; Greven K
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):104-9. PubMed ID: 17084549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique].
    Gamelon-Bénichou C; Oldrini S; Charra-Brunaud C; Vogin G; Salleron J; Peiffert D
    Cancer Radiother; 2017 May; 21(3):171-179. PubMed ID: 28457817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
    Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.